CALA management, unfortunately subpar 2.1 | CALA Message Board Posts

Calithera Biosciences, Inc.

  CALA website

CALA   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  2685 of 2688  at  7/2/2019 5:24:24 PM  by

wilderguide


 In response to msg 2684 by  logansdad
view thread

Re: CALA management, unfortunately subpar 2.1

"Setting aside the management discussion, below is what's interesting about the science."

Great post, logansdad, and worthy of it's own thread.
In the future, I for one, would really appreciate if you would post anew with such information - makes it mush easier to find if backtracking. In addition to your update on the science, there are a couple of foreign studies posted to Pubmed's NCBI database revealing the current academic interest in CB-839 for its extraordinary effect on glutamine to proline conversion. Looking beyond glutaminase treatment in oncology, this research enables the potential for applications in diabetes and other metabolic disorders.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 3     Views: 305
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...